Editor's note: With this issue, we initiate a symposium on the epidemiology of vitamin D. Our Guest Editor, Dr. Cedric Garland, has overseen the project and will provide an overview and commentary at its completion. The current contribution deal with measurement and clinical interpretation of Vitamin D, and with some aspects of the relationship of Vitamin D and cancer. Subsequent issues will continue the discussion of cancer, with attention to the risks of vitamin D and perspectives on its use for cancer prevention. 
INTRODUCTION
The association of sunlight and vitamin D for the promotion of bone health began with the industrialization of northern Europe. The lack of adequate sun exposure resulted in an epidemic of children with severe growth retardation and bony deformities that was commonly known as rickets (1) . In 1919, Huldschinsky et al. (2) reported that exposure to ultraviolet radiation cured rickets. This was followed by Hess and Unger in 1921 (3) , who observed that exposure to sunlight cured rickets.
In the 1930s, it was appreciated that ultraviolet irradiation of yeast extract was effective in producing an antirachitic substance known as vitamin D. This vitamin D was structurally identified and called vitamin D 2 . Vitamin D 3 was identified by the irradiation of 7-dehydocholesterol. Because vitamin D 2 was inexpensive to produce, vitamin D 2 was used widely for the fortification of foods, including milk and bread in the United States and Europe. When 7-dehydrocholesterol was easily extracted from lanolin from sheep's wool, vitamin D 3 was inexpensively made and was used in food fortification and for supplements.
In the early 1950s, there was an outbreak of hypercalcemia, caused by what was thought to be the overfortification of milk with vitamin D and, as a result, most European countries forbid the fortification of milk and other dairy products with vitamin D. In the United States, milk and orange juice are fortified with vitamin D 3 , whereas a majority of multivitamin supplements and pharmaceutical preparations contain vitamin D 2 (1, 4 To remove interfering vitamin D metabolites, simple preparative chromatography was developed to separate 25(OH)D from more polar metabolites that interfered with the assay. In the mid-1970s, high-performance liquid chromatography (HPLC) was applied to the 25(OH)D assay (11, 13) . This assay included a lipid extraction of the serum followed by preparative chromatography and the 25(OH)D fraction was applied to HPLC and the UV absorption of 25(OH)D was used to measure its concentration. HPLC was considered to be the gold standard but was a very cumbersome assay, and, thus, was not routinely used by reference laboratories for clinical samples.
The advances in liquid chromatography tandem mass spectroscopy (LC-MS) were applied for the direct measurement of 25 As a patient becomes vitamin D deficient, there is a decrease in intestinal calcium absorption which lowers ionized calcium transiently. This signal is recognized by the calcium sensor in the parathyroid glands to increase the production and secretion of parathyroid hormone (PTH) (18) . PTH regulates calcium metabolism by increasing tubular reabsorption of calcium in the kidney, increasing mobilization of calcium from the skeleton, and by increasing the renal production of 1,25(OH)D (1, 4, 16) . Thus, as a patient becomes vitamin D insufficient and deficient, the increase in PTH levels result in normal or elevated levels of 1,25(OH)D. This makes the 1,25(OH) 2 D assay useless as a measure of vitamin D status. The 1,25(OH)D assay, however, has been effectively used to help in the diagnosis of several inherited and acquired disorders in calcium metabolism as they relate to alteration in the renal or extra renal production of 1,25(OH)D (4, 16, 19) .
DEFINITION OF VITAMIN D INSUFFICIENCY AND DEFICIENCY
There is no absolute consensus as to what a normal range for 25(OH)D should be. Part of the difficulty is how a normal range is determined, i.e., typically it is done by obtaining blood from several hundred volunteers and deeming them to be normal and to perform the measurement of the analyte and do a distribution with a mean G 2SD as the normal range. However, since it is now recognized that 30-50% of both the European and US population are vitamin D insufficient or deficient, the previously reported normal ranges of 10-55 ng/ml are totally inadequate (1, 4, 16, (20) (21) (22) (23) . Chapuy et al. (24) reported that a dot plot of serum 25(OH)D levels as a function of PTH levels provided an insight as to what the serum 25(OH)D levels should be to be considered sufficient. They observed that the PTH levels began to plateau at their nadir when 25(OH)D levels were between 30 and 40 ng/mL. A similar observation was made by Thomas et al. (25) and Holick (14) (Fig. 2) .
Malabanan et al. (26) did provocative testing by giving healthy adults who had a 25(OH)D of between 11 and 25 ng/mL, 50,000 IU of vitamin D once a week for 8 weeks. At the end of 8 weeks, it was observed that 25(OH)D levels increased on average by more than 100%. An analysis of the change in PTH levels for each of the subjects revealed that on average, the mean decrease on PTH levels declined by 55% in subjects who had 25(OH)D between 11 and 15 ng/mL and decreased by 35% for those with 25(OH)D levels of between 16 and 19 ng/mL. Those subjects who had 25(OH)D O 20 ng/mL had no significant change in their PTH level (Fig. 3) . Thus, based on the provocative testing, it was suggested that vitamin D deficiency should be defined (1, 4, 28) .
The upper limit of normal has also been questioned (4, 29, 30 ). An upper limit of 55 ng/mL seemed to be inadequate, especially since lifeguards who are exposed to a lot of sunlight typically have reported levels of 100-125 ng/mL (4, 16, 29) . There has never been a reported case of vitamin D intoxication from sun exposure, and lifeguards have not been reported to be vitamin D intoxicated. On the basis of the literature, it appears that vitamin D intoxication does not occur until blood levels are O150-200 ng/mL (31, 32) . Vitamin D intoxication is defined as a 25(OH)D O150 ng/m-that is associated with hypercalcemia, hypercalciuria and, often, hyperphosphatemia.
On the basis of all of this information, many of the reference laboratories are now using a normative range for 25(OH)D to be 20-100 ng/mL. However, several reference laboratories are also recognizing the recommendation by some experts that a preferred level of O30 ng/mL is most desirable. (Fig. 4) 3 , is what physicians need to be aware of for their patients. A level O30 ng/mL is now considered to be the preferred healthful level that all children and adults should maintain throughout the year.
